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Abstract
Purpose Although situational risk factors for incisional
hernia formation are known, the methods used to determine
who would be most susceptible to develop one are unre-
liable. We hypothesized that patients with recurrent inci-
sional hernias may possess unique gene expression profiles.
Methods Skin and intact fascia were collected from 15
normal control (NC) patients with no hernia history and 18
patients presenting for recurrent incisional hernia (RH)
repair. Microarray analysis was performed using whole
genome microarray chips on NC (n = 8) and RH (n = 9).
These samples were further investigated using a pathway-
specific PCR array containing fibrosis-related genes.
Results Microarray data revealed distinct differences in
the gene expression profiles between RH and NC patients.
One hundred and sixty-seven genes in the skin and 7 genes
in the fascia were differentially expressed, including 8
directly involved in collagen synthesis. In particular,
GREMLIN1, or bone morphogenetic protein antagonist 1,
was under expressed in skin (fold = 0.49, p \ 10-7,
q = 0.0009) and fascia (fold = 0.23, p \ 10-4,
q = 0.095) of RH patients compared with NC. The PCR
array data supported previous reports of decreased collagen
I/III ratios in skin of RH versus NC (mean = 1.51 ± 0.73
vs. mean = 2.26 ± 0.99; one-sided t test, p = 0.058).
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Conclusion To our knowledge, this is the first micro-
array-based analysis to show distinct gene expression
profiles between the skin and fascia of RH and NC patients
and the first report of an association between GREMLIN1
and incisional hernia formation. Our results suggest that
gene expression profiles may act as surrogate markers that
stratify patients into different groups at risk for hernia
development prior to their initial surgery.
Keywords Ventral hernia  Recurrence  Microarray 
GREM1  Gene expression  Collagen I/III ratio
Abbreviations





IRB Institutional review board
OR Odds ratio
GO Gene ontology
RIN RNA integrity number
Introduction
Incisional hernia repair comprises a significant proportion
of a general surgeon’s practice. The incidence of incisional
hernias ranges from 2 to 11 %, with a substantial recur-
rence rate reported between 10 and 50 % [1]. Based upon
this estimate, 100,000 incisional hernia repairs are pre-
dicted to be performed each year costing $2.5 billion [1].
While recurrence rates have decreased by using prosthetic
mesh in the repair, a significant number of patients develop
multiple recurrences with estimates in the literature ranging
from 5 to 20 % [2].
Several risk factors for developing incisional hernias have
been identified including wound infection, abdominal dis-
tention, pulmonary complications, male gender, age, and
obesity [1]. Although risk factors for recurrent incisional
hernias have also been evaluated, the literature is contro-
versial with regard to many of these, such as body mass
index, ascites, large hernias exceeding 10 cm in width or
length, continued smoking, occupational lifting, and wound-
healing disorders (e.g., hematoma, seroma, infection) [1].
Current data suggest that incisional hernias are com-
monly caused by failure of early surgical wound healing
[3]. Since collagen I provides tensile strength to connective
tissue, and immature collagen III found in early wounds is
weaker, investigations into the collagen I-to-III ratio have
demonstrated a decreased ratio in patients with direct and
indirect hernias as compared with controls [4, 5]. This
decrease in the collagen I/III ratio was attributed to the
relative increase in collagen III synthesis and was also seen
in incisional hernias [4, 6]. Moreover, a decreased collagen
I/III ratio in incisional hernias supports the possibility of a
high-risk group more susceptible to hernia formation [7].
White and colleagues performed a preliminary immuno-
histochemical trial examining the skin and fascia of 16
incisional hernia patients for collagen I and III and com-
pared the ratio to normal foregut collected from bariatric
patients [8]. They found a significant decrease in the ratio
in the skin of the hernia patients but found no difference in
the fascia [8].
While patients with collagen and connective tissue dis-
eases, such as Ehlers–Danlos syndrome, osteogenesis im-
perfecta, and Marfan’s syndrome, are known to form hernias,
there are no data on potential genetic predispositions to
hernia formation in otherwise normal patients [9–11]. We
hypothesized that recurrent incisional hernia formation may
be due to subtle differences in gene expression (mRNA)
profiles that ultimately alter wound healing. We designed a
pilot study comparing the skin and fascia from recurrent
hernia (RH) patients to those who underwent laparoscopic
cholecystectomy (normal control, NC) in order to identify
distinct genomic profiles in the two patient populations.
Methods
Patient samples and tissue acquisition
After obtaining IRB approval and receiving appropriate
informed consent, 33 patients participated in this study.
Patients were eligible if they were 18 years of age or older
and underwent laparoscopic repair of a recurrent ventral or
incisional hernia. Patients were excluded if they were under
18; had a history of steroid use, severe COPD, pulmonary,
or connective tissue disorders; or were prisoners. Eighteen
patients with at least one recurrent incisional hernia pre-
sented for laparoscopic incisional hernia repair. The des-
ignated controls were 15 healthy patients who had no
hernia history and underwent laparoscopic cholecystec-
tomy. Approximately 1 cm2 of skin and fascia was
removed from the trocar placement site, remote from the
hernia or old incisions. The tissue samples were divided
and placed in either 10 % buffered formalin or RNALat-
erTM RNA Stabilization Reagent (Qiagen, Valencia, CA).
Tissue was stored in RNALaterTM for up to 48 h at room
temperature. Approximately 100–150 mg of tissue was
used for RNA isolation.
RNA isolation and RNA amplification
Total RNA was isolated from the skin and fascia specimens
by following the manufacturer’s protocol from the
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RNeasy Lipid Tissue Mini Kit (Qiagen) using a rotor
homogenizer and on-column DNase treatment. Total RNA
was amplified using the WT-OvationTM Pico RNA
Amplification System protocol (NuGen, San Carlos, CA)
as previously described [12, 13].
cDNA labeling, RNA quantity and quality,
and microarray
Of the 33 enrolled patients, 8 NC and 9 RH patients were
selected for microarray analysis based on the quantity,
quality, and integrity of the RNA. For each skin and fascia
sample, 1.5 lg biotin labeled, amplified cDNA was
hybridized to a Sentrix Human-6 v.2 Whole Genome
Expession BeadChips (Sentrix Human WG-6; Illumina,
San Diego, CA) as previously described [13].
Validation by quantitative RT-PCR (qPCR) and PCR
array
cDNA was generated from 10 ng of the same total RNA
samples as used for the microarray experiment (15 patients
analyzed by microarray with sufficient amounts of remaining
high-quality RNA) and SuperScriptTM III Platinum Two-
Step qPCR Kit with SYBR Green (Invitrogen Carlsbad,
CA). For COL1A and GREM1, qPCR was performed on the
StepOneTM Real-Time PCR System (Applied Biosystems,
Foster City, CA) using GAPDH as a reference gene as pre-
viously described [13]. A PCR array, focusing on the
expression of 84 key genes related to dysregulated tissue
remodeling during wound healing, was also performed on
these 15 patients by Global Biologics (Columbia, MO).
Briefly, RNA quantity and purity were assessed using
NanoDrop ND-2000 (Nanodrop Technologies, Wilmington,
DE, USA). RNA integrity was evaluated using the RNA
integrity algorithm generated by the Bioanalyzer 2100 with
the Eukaryotic RNA Pico Series II reagents (Agilent Tech-
nologies, Santa Clara, CA, USA). RIN values ranged from 5
to 8. RNA was reverse transcribed with the RT2 First Strand
cDNA kit (SABiosciences, Frederick, MD), and qPCR was
performed using the Human Fibrosis RT2 ProfilerTM PCR
Array System (SABiosciences, Frederick, MD) and the
Roche LightCycler480 instrument. As part of the qPCR
quality assessment process, each sample was evaluated for
the presence of genomic cDNA contamination, followed by
three positive PCR and three reverse transcriptase controls.
The chosen housekeeping or reference gene, RPL13A, was
selected from a panel of five housekeeping genes on the array
based on the most uniform expression range across all
samples. GREM1 and COL1A qPCR data were statistically
compared using a two-sample t test on the DCt values. The
PCR array data were compared between groups using a
moderated t test on the DCt values as long as the gene was
considered to be reliably expressed (Ct \ 35 in 75 % of
samples) [14].
Immunohistochemistry
Specimens were fixed in 10 % buffered formalin, routinely
processed, embedded in paraffin, and cut at 4 lm. Immu-
nohistochemistry was performed using the automated
horseradish peroxidase Autostainer/Envision Plus method
(Dakocytomation, Carpenteria, CA) as previously descri-
bed [15, 16].
Statistical analysis of microarray data
Analysis of microarray gene expression data was primarily
performed using R open-source software (R Foundation,
Vienna, Austria). Any genes considered ‘‘not detectable’’
(Illumina software detection \1 %) across [50 % of patient
samples were excluded from further statistical analyses in
order to reduce false positives. Nonspecific filtering was also
carried out to remove genes with little variability as previously
described [17]. Differential gene expression analysis was
performed using a moderated t statistics applied to the log2-
transformed normalized intensity for each gene using an
empirical Bayes approach [14]. Adjustment for multiple
testing was made using the false discovery rate method of
Benjamini and Hochberg with a significance cutoff of
q \ 30 % [18], since the list of discovered genes was rela-
tively small. We declared a gene differentially expressed if it
was statistically significant after adjusting for multiple testing
and had a fold change C 1.5 (either over- or under expressed).
Gene ontology (GO) analyses were conducted on the
resulting list of significantly different genes to test their
association with independently established GO terms to shed
insight on the common functions of the differentially identi-
fied genes. We carried out GO analyses for overrepresentation
of biologic process, molecular function, and cellular compo-
nent ontologies, which generated an odds ratio (OR) and
p value for each GO category, using methods previously
described [13]. A small p value (\0.05) and large OR indi-
cated that the number of selected genes associated with a given
term (e.g., wound healing) was larger than expected due to
chance. GO categories containing less than 10 genes repre-
sented on the array were not considered to be statistically
reliable indicators and were not reported even if significant.
Results
Demographics
Demographics for the 33 enrolled patients and the subset of
17 patients whose samples were analyzed by microarray
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are shown in Table 1. The majority (26/33) of enrolled
patients were female, and all but one sample analyzed by
microarray were from females. The RH and NC groups
analyzed by microarray were comparable (p [ 0.05) on all
demographics except diabetes (p = 0.03) and previous
surgery (p = 0.01), neither of which is unexpected in these
populations.
Identification of differential gene expression in the skin
and fascia of RH patients via microarray
Illumina microarray data revealed that 142 complete genes
and 25 expressed sequence tags (ESTs) for a total of 167
genes were differentially expressed in the skin, and 6
complete genes and 1 EST were differentially expressed in
fascia for a total of 7 genes. While the full results are
included in Online Resources 1 and 2, a representative list
of genes is reported in Tables 2 and 3. These were selected
based on our interest in hernia formation and wound heal-
ing, as well as regulation of transcription and immunology.
Eight discovered genes were directly involved in col-
lagen synthesis (PCOLCE2, CTHRC1, COL1A1, COL3A1,
COL4A1, COL5A1, COL5A2, and COL6A3). Moreover, as
supported by the literature, several have been associated
with hernia formation, Ehlers–Danlos syndrome, and
Marfan’s syndrome (e.g., COL1A1, COL3A1, COL5A1,
FBN1, and TIMP1).
A novel and unexpected gene found to be statistically
significant in both the skin and fascia was GREMLIN1
(GREM1, also known as cysteine knot superfamily 1, BMP
Antagonist 1, CKTSF1B1; induced in high glucose 2, IHG-2;
and down regulated by v-mos, DRM) [19]. In fascia, GREM1
had a fold change of 0.23 (q = 0.095, p \ 10-4), while in
skin, it was found to have a fold change of 0.49 (q = 0.0009,
p \ 10-7). GREM1 was under expressed in both the skin and
fascia of RH patients in comparison with NC.
Gene ontology analysis of differentially expressed
genes
Gene ontology analyses were performed to determine
whether there were common functions or descriptive terms
that were statistically abundant in the list of differentially
expressed genes, as quantified by odds ratios. Although the
fascia gene list was too sparse for analysis, in skin we
found more than 53 biologic process (BP) enriched terms,
18 enriched molecular function (MF) terms, and 10 cellular
component (CC) terms (Online Resources 3, 4, and 5).
Table 4 represents a sample of important biologic pro-
cesses that we found to be differentially enriched in skin. For
example, in the skin of RH patients, many differentially
expressed genes were found to be more abundant than
expected in biologic processes such as: response to wounding;
regulation of immune response; activation of plasma proteins
during acute inflammatory response; lipid metabolic process;
multicellular organismal development; and cell adhesion.
Moreover, these analyses illustrate that many genes such as
the collagen genes have diverse functions and appear in sev-
eral BP categories. For instance, COL3A1 and FBN1 were
associated with response to wound healing, blood coagulation,
regulation of body fluids, as well as organ development.
COL3A1 was also associated with regulation of immune
response, regulation of multicellular organismal process,
negative regulation of response to stimulus, cell–matrix
adhesion, and negative regulation of immune system process.
Validation of gene expression by qPCR and PCR array
Based upon the Illumina microarray results, COL1A1 and
GREM1 were selected for validation by qPCR. COL1A1
was overexpressed (2.33 fold) in the skin of RH patients as
compared to NC, but was under expressed (0.34 fold) in the
fascia. GREM1 was under expressed in both the skin (2.6
fold) and fascia (11.2 fold) of RH patients in comparison
with NC (Online Resource 6). In order to explore the
relationship between other relevant wound-healing genes,
such as COL1A1 and COL3A1, a PCR array was used to
measure gene expression on a subset of 15 remaining
patient samples. Eighty genes on the PCR array were
reliably expressed and were analyzed for differences. The
PCR array results confirmed the microarray data as illus-
trated by the strong agreement of fold change (Pearson
r = 0.74, p \ 10-7) among the 39 genes common to both
arrays which were detectable (Fig. 1). The 22 genes with
Table 1 Demographics of
enrolled patients and the subset
analyzed by microarray
Characteristics Patients enrolled Patients analyzed by microarray
RH (n = 18) NC (n = 15) p RH (n = 9) NC (n = 8) p
Sex (M/F) 4/14 3/12 0.99 0/9 1/7 0.47
Age 553.2 44.9 0.14 50.9 39.1 0.23
BMI 36.6 30.5 0.03 39.2 31.4 0.10
Smoker 8 2 0.07 4 2 0.62
Diabetes 7 0 0.01 5 0 0.03
Previous surgery 18 6 0.01 9 3 0.01
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large fold changes found by PCR array are reported in
Table 5, with results for all genes on the PCR array pre-
sented in Online Resource 7. The distributions of patient
expression levels from the PCR array for four selected
differentially expressed genes overlap less than 50 % on
average (Fig. 2).
Table 2 Selected genes from skin of RH patients significantly over- or under expressed in comparison with skin from NC, in ascending order of
fold change (NC/RH)
Gene symbol Fold change Gene name
GREM1 0.49 Gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis)
TP63 0.5 Tumor protein p63
KRT15 0.53 Keratin 15
TFAP2C 0.59 Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
KLF5 0.63 Kruppel-like factor 5 (intestinal)
ELL2 0.66 Elongation factor, RNA polymerase II, 2
NAP1L1 0.66 Nucleosome assembly protein 1-like 1
COL5A2 1.51 Collagen, type V, alpha 2
PDXK 1.51 Pyridoxal (pyridoxine, vitamin B6) kinase
GHR 1.54 Growth hormone receptor
NUCB1 1.55 Nucleobindin 1
CD81 1.56 CD81 molecule
RBPMS2 1.59 RNA binding protein with multiple splicing 2
TIMP1 1.59 TIMP metallopeptidase inhibitor 1
ANXA5 1.59 Annexin A5
CAV1 1.60 Caveolin 1, caveolae protein, 22 kDa
THY1 1.62 Thy-1 cell surface antigen
PMP22 1.62 Peripheral myelin protein 22
COL5A1 1.63 Collagen, type V, alpha 1
FBLN1 1.63 Fibulin 1
FBN1 1.63 Fibrillin 1
CLDN5 1.66 Claudin 5 (transmembrane protein deleted in velocardiofacial syndrome)
MSX1 1.66 Msh homeobox 1
COL1A2 1.69 Collagen, type I, alpha 2
PDGFRB 1.7 Platelet-derived growth factor receptor, beta polypeptide
FAP 1.74 Fibroblast activation protein, alpha
DCN 1.74 Decorin
MCAM 1.79 Melanoma cell adhesion molecule
COL6A3 1.8 Collagen, type VI, alpha 3
CILP 1.99 Cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
LUM 2.03 Lumican
COL1A1 2.05 Collagen, type I, alpha 1
FZD4 2.11 Frizzled homolog 4 (Drosophila)
CTHRC1 2.17 Collagen triple helix repeat containing 1
HSPB6 2.17 Heat shock protein, alpha-crystallin-related, B6
RBP4 2.17 Retinol binding protein 4, plasma
COL3A1 2.3 Collagen, type III, alpha 1
COL4A1 2.43 Collagen, type IV, alpha 1
ANGPTL2 2.7 Angiopoietin-like 2
CD36 3.07 CD36 molecule (thrombospondin receptor)
FSTL1 3.15 Follistatin-like 1
PCOLCE2 3.64 Procollagen C-endopeptidase enhancer 2
LEP 5.03 Leptin
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COL1/COL3 ratio by microarray, PCR array,
and immunohistochemistry
By microarray, COL1A1/COL3A1 ratio in skin of RH
patients was slightly lower than NC patients, but was not
significant (1.33 vs. 1.46, p = 0.65). Similar but significant
results were found for COL1A2/COL3A1 (0.59 vs. 0.79,
p = 0.02). Neither of these ratios were statistically differ-
ent in the fascia. Immunohistochemistry on 5 patients
demonstrated slightly greater staining intensity of COL3A1
than COL1A1 in the skin and fascia from RH patients in
comparison with NC. Analysis by PCR array revealed that
gene expression of COL3A1 was greater than COL1A2 (the
second alpha chain of the collagen 1 molecule) in skin in
both groups. According to the manufacturer, COL1A2 was
selected because it was referenced more often in relation to
fibrosis in public data bases than COL1A1. Moreover, the
ratio of COL1A2/COL3A1 was decreased in the RH group
as compared to NC (1.51 vs. 2.26, p = 0.058, one-sided
t test). These results agree with reports in the literature
[4–12].
The gene expression ratio of COL1A2/COL3A1, in
conjunction with GREM1, was explored as a means of
stratifying patients into NC or RH. We also considered
COL1A2 and COL3A1 on their own (i.e., not in ratio form)
in combination with GREM1. All pairwise combinations of
these 4 markers were considered as means of classifying
patients into their correct group (RH or NC) using
quadratic discriminant analysis (QDA). QDA may be
thought of as a method that yields the best curve (‘‘sepa-
ration boundary’’) that can be drawn in order to maximize
the separation between the group means. We found that by
using leave-one-out cross-validation, the combination of
{GREM1, COL3A1} (Fig. 3) achieved the highest accuracy
(86 %), followed by either {COL3A1, COL1A2} or
{COL1A2, COL1A2/COL3A1} at 73 % accuracy, and
{GREM1, COL1A2} or {GREM1, COL1A2/COL3A1} at
66 % accuracy.
Discussion
The molecular biology of hernia repair is largely unknown.
Equally unclear is why incisional hernia repairs, either
laparoscopic or open, frequently recur. We designed a pilot
study, using microarrays, to identify potentially specific
gene profiles in patients with recurrent incisional hernias
(RH). We analyzed the skin and fascia from these patients
and compared them to skin and fascia taken from patients
who had no history of hernias (NC).
Our study was unique both in using a genomic-based
approach (microarray and PCR array) and in taking skin
and fascia samples away from the site of the incisional
hernia. The acquisition of skin and fascia at the start of the
procedure, prior to trocar placement, allowed us to avoid
the confounder of biologic and pathologic processes
occurring in the hernia (e.g., inflammation, wound healing)
that could skew our results. Wound infection, for instance,
has been widely reported as the most significant indepen-
dent prognostic factor for incisional hernia [1, 20–22].
Although technical factors such as type of repair or use of
mesh have been attributed to cause recurrence, they do not
explain all hernia recurrences [1]. We theorized that vari-
ations in gene expression may play a role in wound healing
and recurrence.
Our experiments have shown distinct gene expression
profiles between the skin and fascia of RH and NC patients.
When comparing active gene expression profiles, we found
Table 3 Selected genes from fascia of RH patients over- or under
expressed in comparison with fascia from NC patients in ascending
order of fold change (NC/RH)
Gene symbol Fold change Gene name
GREM1 0.23 Gremlin 1
PRLR 0.39 Prolactin receptor
LEFTY 0.43 Left–right determination factor
SCRG1 0.44 Scrapie responsive protein 1
RNF144A 0.49 Ring finger protein 1
PDZRN4 0.54 PDZ domain containing ring finger 4
Table 4 Selected results from GO analysis of biologic processes in list of differentially expressed genes from skin samples
GO ID OR p Term Differentially expressed genes in term
0002541 7.01 0.039 Activation of plasma proteins involved in
acute inflammatory response
CFD, CFH
0007160 6.62 0.001 Cell–matrix adhesion COL3A1, ECM2, NID1, EPDR1, THY1
0050776 4.89 0.012 Regulation of immune response COL3A1, CFD, CFH, THY1
0009611 3.18 0.001 Response to wounding COL3A1, CFD, FABP4, FBN1, CFH, ANXA5, PROK2, VWF, CAV1,
AOC3, CD36
0007155 2.36 0.007 Cell adhesion FERMT2, COL5A1, COL6A3, VCAN, DPT, ISLR, LAMA4, MCAM,
MFAP4, S100A4, CLDN5, AOC3, CD36
These terms are more abundant than expected and are sorted by odds ratio (OR)
198 Hernia (2013) 17:193–202
123
more statistically significant genes in the skin than the fascia.
We found greater variability in gene expression in fascia than
skin in our samples, which is apparent graphically (Online
Resources 8 and 9). Since an increase in variance reduces the
power to detect differences, this is the most obvious expla-
nation for the shorter fascia gene list. The functions of the
genes in the skin were diverse and included wound healing,
transcription regulation, and immunology.
The sparse number of genes in the fascia precluded GO
analysis. In the skin, GO analysis further expanded these to
53 BP functions, including regulation of the immune and
inflammatory responses, organ development, and cell
adhesion. GO analysis also revealed 10 CC and 18 MF cat-
egories, with most genes associated with the extracellular
region and plasma membrane, and enzyme inhibitor activity
and receptor binding, respectively. The relationship of these
genes to known biologic functions can assist in our under-
standing of the basic science of hernia formation.
One of our most intriguing findings was altered GREM1
expression in the skin and fascia of RH patients. Originally
isolated from the neural crest of the Xenopus as a bone
morphogenetic protein (BMP) antagonist, GREM1 is an
important regulator of limb development and may play a
role in regulating organogenesis, body patterning, as well
as tissue differentiation [19, 23, 24]. High levels have been
found in nondividing and terminally differentiated cells
such as neurons, alveolar epithelial cells, and goblet cells
[19, 24]. An earlier name of GREM1 was IHG-2 because
its expression in glomerular mesangial cells was induced
by high glucose, mechanical strain, and TGF-b [25].
GREM1 has been suggested to be a modulator of mesangial
cell proliferation and epithelial–mesenchymal transdiffer-
entiation in diabetes and has been shown to have increased
expression in various diabetic nephropathy models as well
as being involved in the pathophysiology of progressive
renal fibrogenetic diseases [26, 27]. Moreover, gene and
protein expression have been reported in fibroblast cultures
harvested from patients diagnosed with systemic sclerosis
[28].
Although GREM1 has not been associated with hernia
formation or wound healing, it has been found in the
stromal cells of basal cell carcinomas [29]. This group also
reported a concomitant expression of FOLLISTATIN (FST)
in the stromal cells of basal cell carcinomas [29]. Inter-
estingly, our data showed that FST-like 1 expression
accompanied GREM1 expression in the skin of recurrent
incisional hernia patients. The findings in the literature
support a role for GREM1 in fibrosis of the skin and kidney
and are suggestive of a role in hernia formation. The
Agreement of findings between microarray 



























































(n=17) and PCR array (n=15)
Fig. 1 Agreement of microarray and PCR array results. The genes
which were detected on both the microarray and the PCR array are
plotted against their fold change (RH/NC) for each platform. Bold
italicized gene symbols indicate they were significantly different
based on microarray data
Table 5 Genes sorted by fold change (RH/NC) in skin by PCR array
with fold changes [2 or \0.5 between RH (n = 8) and NC (n = 7),
where * denotes p \ 0.05























Hernia (2013) 17:193–202 199
123
potential role of GREM1 becomes further substantiated
when viewed from a perspective that defects in normal
wound healing and mechanical strain are frequently cited
as causes of hernia formation and recurrence. Although our
microarray data were validated by qPCR and PCR array,
we are in the process of further testing the role of GREM1
in an expanded population of patients.
More conventional genes of interest from our study were
the 8 genes directly involved with collagen synthesis and
those associated with hernia formation, Ehlers–Danlos
syndrome, and Marfan’s syndrome such as FBN1. Our data
on COL1A1 and COL3A1 were validated by qPCR and
PCR array. The ratio of collagen I to collagen III decreased
in the RH patients in comparison with NC as would be
expected according to the literature [4–8]. These data are
strengthened by the fact that a decrease was seen regardless
of which collagen 1 alpha chain was analyzed. The clinical
manifestations of Marfan’s suggest that alterations in
connective tissue stability may play an important role.
Mutations in FBN1 are known to cause Marfan’s syndrome
and have been associated with tissue stability [30].
Recently, an immunohistochemcial study was performed
on scar and nonscar regions of human skin and fascia [30].
The authors studied 22 patients who underwent repeated
laparotomy: 12 had developed incisional hernia and 10 did
not and were used as control. They found that FBN1 may
be an important contributing factor to tissue stability and
incisional hernia formation [30].
Although the size of our study may be viewed as a
potential limitation, it is important to emphasize that this
was a limited pilot study to assess the feasibility of whether
recurrent incisional hernia formation is due to differing
gene expression profiles that alter wound healing. The
statistical power generated from a larger study that could
incorporate adjustments for demographic variables should
further substantiate our results. These data would be used
to enhance our knowledge of the molecular biology of
hernia formation and wound healing. In addition, the gene
expression profiles would have both narrow and broad
ramifications. For instance, they could predict which ven-
tral hernia patients might be more likely to recur, and
potentially offer targeted, patient-specific therapies for the
prevention of recurrent incisional hernia such as type of
mesh and repair method. A limited investigation of this
possibility showed that the combination of GREM1 and
COL3A1 have potential in this regard (Fig. 3). It is not
surprising, since COL1A2, COL3A1, GREM1, and IL10 all
show promise as biomarkers (either individually or more
powerfully in the form of a panel) due to the minimal





































genes by PCR array
Fig. 2 Patient-level gene expression data for 4 selected genes from
PCR array with group median indicated by a horizontal line






















































Separation of patients using GREM1 and COL3A1
Fig. 3 Ability of the combination of GREM1 and COL3A1 gene
expression to separate RH and NC patients. PCR array data were used
to explore the utility of gene expression of GREM1 and COL3A1 as
markers to distinguish RH and NC patients. The best separation
boundary (solid line) was determined using quadratic discriminant
analysis. Using all of the data, only 1 patient (RH, gray) was
misclassified (93 % accuracy). Using leave-one-out cross-validation,
in which each patient’s data is held out (in turn) during the calculation
of the best boundary and subsequently evaluated for accuracy, 13/15
(86 %) patients were correctly classified
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overlap in the RH and NC groups for each of these genes
(Fig. 2). From a broader vantage point, however, profiles
could be generated from a preoperative assay that would
also stratify patients into low- and high-risk populations of
prospective hernia formers or poor wound healers. Ulti-
mately, this would lead to the development of rapid and
standardized wound-healing methods providing minimal or
no postoperative complications.
Conclusion
In summary, using microarray analysis, we have performed
for the first time a genome-wide pilot study of patients who
have recurrent incisional hernias. We have identified dis-
tinct gene expression profiles in these patients and have
furthered our understanding of recurrent incisional hernia
formation. Moreover, we have found an association
between a novel gene to the hernia literature, GREM1, and
incisional hernia formation. To our knowledge, this is the
first report to demonstrate such an association. Based upon
our results, gene expression profiles may act as surrogate
markers that stratify patients into different groups at risk
for hernia development prior to their initial surgery. Further
investigation using a larger patient population is planned to
substantiate these results and potentially provide novel
insights into hernia formation, wound healing, and ulti-
mately targeted, patient-specific therapy.
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